RG7112 (RO5045337)

RG7112 · Hoffmann-La Roche

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for RG7112 (RO5045337), covering 2016-11-02 to 2016-11-02. Get the full timeline:

Most recent: Clinical Trial Update: A Study of RO5045337 [RG7112] in Patients With Hematologic Neoplasms. [Phase 1]